Literature DB >> 6945991

Binding of one monoclonal antibody to human Ia molecules can be enhanced by a second monoclonal antibody.

R Tosi, N Tanigaki, R Sorrentino, R Accolla, G Corte.   

Abstract

A monoclonal anti-human Ia antibody, PTF 29, was tested for its ability to bind purified, 125I-labeled human Ia preparations. It was found that the binding level increases considerably in the presence of a second monoclonal antibody. Experimental conditions were selected under which only the binding of PTF 29 and not the binding of the second antibody could be determined. Under these conditions, it was found that "helped" PTF 29 binding has higher affinity and is exerted on a molecular subset different from that bound by PTF 29 alone. This phenomenon, while not easily accommodated in the present conceptual framework of the human Ia system, appears in itself interesting and may have more general implications.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6945991     DOI: 10.1002/eji.1830110910

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  The monoclonal antibody CR11-351 discriminates HLA-A2 variants identified by T cells.

Authors:  C Russo; A K Ng; M A Pellegrino; S Ferrone
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

2.  Enhancing antibody: a novel component of the immune response.

Authors:  D A Nemazee; V L Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

3.  Incidence of T cell subset imbalance in relatives of Graves' disease patients.

Authors:  P Biassoni; G Ciprandi; S Ferrini; G Chimini; G W Canonica; M Bagnasco
Journal:  J Endocrinol Invest       Date:  1984-04       Impact factor: 4.256

4.  Dissecting the antigenic mosaic of the Archaebacterium Methanobacterium thermoautotrophicum by monoclonal antibodies of defined molecular specificity.

Authors:  E Conway de Macario; A J Macario; M C Magariños; H König; O Kandler
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

5.  In vitro selective expansion of allergen specific T cells from atopic patients.

Authors:  A Lanzavecchia; P Santini; E Maggi; G F Del Prete; P Falagiani; S Romagnani; M Ferrarini
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

6.  Circulating T cell subsets in euthyroid Graves' disease.

Authors:  M Bagnasco; G W Canonica; S Ferrini; G Ciprandi; W Dirienzo; G Giordano; O Ferrini
Journal:  J Endocrinol Invest       Date:  1983-04       Impact factor: 4.256

7.  Functional characterization of an antigen involved in an early step of T-cell activation.

Authors:  M E Cosulich; A Rubartelli; A Risso; F Cozzolino; A Bargellesi
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

8.  Autoimmune thyroid disease: purification and phenotypic analysis of intrathyroid T cells.

Authors:  G W Canonica; M Caria; G Torre; A Risso; M E Cosulich; M Bagnasco
Journal:  J Endocrinol Invest       Date:  1984-12       Impact factor: 4.256

9.  A monoclonal anti-DC1 antibody selectivity inhibits the generation of effector T cells mediating specific cytolytic activity.

Authors:  G Corte; A Moretta; M E Cosulich; D Ramarli; A Bargellesi
Journal:  J Exp Med       Date:  1982-11-01       Impact factor: 14.307

10.  Multiple class I and class II major histocompatibility complex allospecificities are generated with T cell receptor variable (V) domains created by a single Ti beta V gene family.

Authors:  O Acuto; R E Hussey; E L Reinherz
Journal:  J Exp Med       Date:  1985-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.